News

 
London, 18th December 2023 - Kadans Science Partner (“Kadans”) has added a new asset in King’s Cross, London, UK to its Pan-European portfolio. The new asset at 22-23 Tileyard Road will be delivered as purpose built, high-quality laboratory accommodation, providing much needed technical real estate to the King’s Cross and London market. The asset was acquired from City & Provincial Properties. This latest acquisition continues to grow Kadans’ footprint in the Knowledge Quarter, London, a global centre of excellence for science & technology innovation.

Read the December eNews #lifescience newsletter featuring:

OXFORD, BRISTOL, EDINBURGH, UK – 15 December 2023 – Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.

We are excited to reach out to you, CEBR (Council of European BioRegion), ne

As 2023 concludes, Biocair, an established global leader in life sciences logistics, proudly announces a year of remarkable achievements. With significant strides in sustainability, strategic partnerships and global expansion, Biocair affirms its commitment to being the specialist in temperature-controlled logistics for the life sciences industry.


Sustainability at the forefront:

Cancer Research UK has appointed industry veteran Dr Lars Erwig as the new director for its Centre for Drug Development, the world's only charity-funded drug development facility.


With Cancer Research UK’s aim to beat cancer, the centre has a critical role to play in partnering with others to ensure that pre-clinical and early-phase clinical projects with the highest potential for patient benefit are prioritised and rapidly advanced.

Specialist Intellectual Property law firm Reddie & Grose is delighted to introduce its brand-new podcast series, ‘Talk IP with R&G’.


Hosted by experts from across the firm, the regular podcast is a go-to resource on how businesses can make the most of their intellectual property.  

Pioneer Group, a company combining laboratory development and operation with venture building, is continuing its collaboration with Innovate UK by bringing its venture development ‘Launch Programme’ to the Exploit stage of Innovate UK’s ICURe programme.


The Launch Programme welcomes invited life science founders from the ICURe Programme, as well as the Pioneer Group ecosystem, to provide support in accelerating their development from lab to market adoption.








London, UK; December 11, 2023 — AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced the appointment of John Isaac, Ph.D., as Chief Scientific Officer. Previous interim Chief Scientific Officer and AviadoBio co-founder, Professor Chris Shaw, will remain an active member of the leadership team and resume his prior roles as Chief Scientific and Clinical Advisor and Board Observer.

Download the My Green Lab 2023 Carbon Impact of Biotech & Pharma report now!


Pages